Quantinuum (NASDAQ:QNT) Stock Crosses Below 50-Day Moving Average – Should You Sell?

Quantinuum Inc. (NASDAQ:QNT – Get Free Report) shares passed below its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $42.93 and traded as low as $40.09. Quantinuum shares last traded at $40.57, with a volume of 3,032,547 shares changing hands.

Quantinuum News Summary

Here’s some of the latest news about QNT:

  • Positive Sentiment: Quantinuum and RIKEN expanded their partnership to advance quantum-AI hybrid supercomputing in Japan. Quantinuum’s Reimei system has been upgraded to its H2 system, supporting more complex research and work in fields including electronics, energy and life sciences. The partners also plan to develop a fault-tolerant quantum computer. Article
  • Neutral Sentiment: A short-interest report lists zero shares sold short and a zero-day days-to-cover ratio as of November 10, suggesting short selling was not a notable source of pressure based on the reported figures. Short interest data
  • Negative Sentiment: Bank of America cut its price target for QNT, a potentially negative signal for investor sentiment. The available report does not specify the revised target or the rationale for the cut. Article

Analyst Upgrades and Downgrades

A number of research analysts have commented on QNT shares. Jefferies Financial Group reduced their price objective on shares of Quantinuum from $85.00 to $65.00 and set a “buy” rating on the stock in a research note on Friday, November 6th. Bank of America dropped their target price on shares of Quantinuum from $85.00 to $50.00 and set a “buy” rating for the company in a research report on Monday. JPMorgan Chase & Co. cut their target price on shares of Quantinuum from $97.00 to $80.00 and set an “overweight” rating on the stock in a research note on Friday, November 6th. Wall Street Zen upgraded shares of Quantinuum from a “sell” rating to a “hold” rating in a research note on Saturday, November 7th. Finally, Needham & Company LLC reduced their price target on shares of Quantinuum from $100.00 to $60.00 and set a “buy” rating on the stock in a research report on Friday, November 6th. Thirteen research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $81.77.

View Our Latest Analysis on Quantinuum

Quantinuum Price Performance

The business has a 50-day simple moving average of $42.93. The company has a market capitalization of $10.68 billion and a PE ratio of -54.09.

Quantinuum (NASDAQ:QNT – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.99) by $0.70. The firm had revenue of $9.05 million during the quarter. On average, analysts anticipate that Quantinuum Inc. will post -4.76 EPS for the current fiscal year.

Institutional Trading of Quantinuum

Institutional investors have recently made changes to their positions in the stock. CoreCap Advisors LLC acquired a new stake in Quantinuum in the third quarter worth approximately $32,000. Fifth Third Bancorp boosted its position in shares of Quantinuum by 1,530.2% in the 3rd quarter. Fifth Third Bancorp now owns 1,027 shares of the company’s stock valued at $49,000 after purchasing an additional 964 shares during the period. IFP Advisors Inc boosted its holdings in shares of Quantinuum by 1,150.0% in the third quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock worth $60,000 after buying an additional 1,150 shares during the period. GW&K Investment Management LLC acquired a new position in Quantinuum in the 3rd quarter worth approximately $82,000. Finally, Russell Investments Group Ltd. acquired a new stake in shares of Quantinuum in the third quarter worth $97,000.

About Quantinuum

(Get Free Report)

Quantinuum develops quantum computers, software and cybersecurity products for businesses, researchers and government organizations. Its work includes trapped-ion quantum systems, tools for programming and managing quantum applications, and services focused on quantum chemistry and data security. The company was formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum, bringing together quantum hardware and software capabilities. Its offerings include the H-series quantum computers, the TKET software development kit and InQuanto, a platform for quantum chemistry research.

Featured Articles

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.